R. Wang et al.
After cooling to room temperature, 2a–2e (10.0 mmol), CuSO4·5H2O
(0.37 g, 1.5 mmol) and sodium ascorbate (0.90 g, 4.5 mmol) were added,
and the reaction mixture allowed to stir at ambient temperature for 24 h.
The resulting solution was extracted with n-butyl alcohol (3ꢂ20 mL).
The combined organic phase was washed with water and brine and dried
over MgSO4, concentrated under reduced pressure, and purified by flash
chromatography on silica gel to give 3a–3i.
tate (3ꢂ10 mL). The combined organic layer was washed with water (3ꢂ
10 mL) and evaporated to dryness in vacuo to give 4a–4n.
1,2-Dimethyl-3-[(1-butyl-1H-1,2,3-triazol-4-yl)methyl]-1H-imidazol-3-ium
hexafluorophosphate (4a): White solid, yield: 82%. 1H NMR (CD3OD):
d=8.06 (s, 1H), 7.46 (s, 1H), 7.42 (s, 1H), 5.47 (s, 2H), 4.40 (t, J=
7.2 Hz, 2H), 3.82 (s, 3H), 2.70 (s, 3H), 1.90–1.83 (m, 2H), 1.35–1.29 (m,
2H), 0.94 (t, J=7.6 Hz, 3H); 13C NMR (CD3OD): d=145.1, 140.5, 124.1,
122.4, 120.8, 49.9, 47.3, 42.7, 34.1, 31.7, 19.2, 12.4, 8.4; 31P NMR
(CD3OD): d=À144.6; 19F NMR (CD3OD): d=À74.3 (d, J=706 Hz, 6F);
IR (KBr, cmÀ1): n˜ = 3165 (m), 2962 (m), 2875 (w), 1594 (m), 1541 (m),
1452 (m), 1392 (w), 1249 (s), 1140 (w), 1052 (m), 835 (vs), 791 (s), 762
(w), 741 (w), 559 (s); elemental analysis (%) calcd for C12H20F6N5P
(379.3): C 38.00, H 5.31, N 18.46; found C 38.12, H 5.25, N 18.39.
1,2-Dimethyl-3-[(1-butyl-1H-1,2,3-triazol-4-yl)methyl]-1H-imidazol-3-ium
bromide (3a): Yellow solid, yield: 56%. 1H NMR (CD3OD): d=8.21 (s,
1H), 7.57 (s, 1H), 7.52 (s, 1H), 5.54 (s, 2H), 4.44 (t, J=7.2 Hz, 2H), 3.86
(s, 3H), 2.76 (s, 3H), 1.95–1.85 (m, 2H), 1.40–1.30 (m, 2H), 0.98 (t, J=
7.2 Hz, 3H); 13C NMR (CD3OD): d=145.1, 140.5, 124.1, 122.5, 120.9,
50.0, 42.7, 34.3, 31.9, 19.2, 12.4, 8.7.
1-Methyl-3-[(1-butyl-1H-1,2,3-triazol-4-yl)methyl]-1H-imidazol-3-ium
hexafluorophosphate (4b): Colorless oil, yield: 85%. H NMR (CD3OD):
1-[(1-Butyl-1H-1,2,3-triazol-4-yl)methyl]-3-methylimidazol-3-ium
bro-
1
mide (3b): Yellow solid, yield: 94%. 1H NMR (CD3OD): d=9.14 (s,
1H), 8.30 (s, 1H), 7.72 (s, 1H), 7.65 (s, 1H), 5.63 (s, 2H), 4.47 (t, J=
7.2 Hz, 2H), 3.99 (s, 3H), 1.95–1.87 (m, 2H), 1.39–1.34 (m, 2H), 0.98 (t,
J=7.4 Hz, 3H); 13C NMR (CD3OD): d=140.3, 136.8, 124.5, 123.9, 122.3,
50.0, 43.9, 35.4, 31.9, 19.3, 12.4.
d=8.88 (s, 1H), 8.11 (s, 1H), 7.61 (s, 1H), 7.55 (s, 1H), 5.53 (s, 2H), 4.43
(t, J=7.2 Hz, 2H), 3.93 (s, 3H), 1.92–1.82 (m, 2H), 1.40–1.30 (m, 2H),
0.96 (t, J=7.2 Hz, 3H); 13C NMR (CD3OD): d=140.3, 136.7, 124.5,
123.8, 123.7,122.2, 122.1, 50.0, 43.7, 35.2, 31.7, 19.2, 12.3; 31P NMR
(CD3OD): d=À144.5; 19F NMR (CD3OD): d=À73.7; IR (KBr, cmÀ1): n˜
= 3164 (s), 2964 (s), 2877 (m), 2119 (w), 1575 (s), 1455 (m), 1385 (w),
1331 (w), 1228 (w), 1166 (s), 1055 (m), 839 (vs), 785 (m), 757 (m), 623
(m), 558 (s); elemental analysis (%) calcd for C11H18F6N5P (365.3): C
36.17, H 4.97, N 19.17; found C 36.15, H 5.00, N 19.52.
1,2-Dimethyl-3-[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]-1H-imidazol-3-
1
ium bromide (3c): Yellow solid, yield: 63%. H NMR (CD3OD): d=8.22
(s, 1H), 7.56 (s, 1H), 7.55 (s, 1H), 7.40–7.30 (m, 5H), 5.63 (s, 2H), 5.52
(s, 2H), 3.84 (s, 3H), 2.74 (s, 3H); 13C NMR (CD3OD): d=145.0, 140.9,
135.1, 128.7, 128.3, 127.91, 124.0, 122.5, 120.9, 53.7, 42.7, 34.2, 8.62.
1,2-Dimethyl-3-[(1-butyl-1H-1,2,3-triazol-4-yl)methyl)-1H-imidazol-3-ium
bis(trifluoromethylsulfonyl)amide (4c): Colorless oil, yield: 85%.
1H NMR (CD3OD): d=8.12 (s, 1H), 7.51 (s, 1H), 7.47 (s, 1H), 5.50 (s,
2H), 4.42 (t, J=6.8 Hz, 2H), 3.84 (s, 3H), 2.73 (s, 3H), 1.92–1.85 (m,
2H), 1.36–1.30 (m, 2H), 0.97 (t, J=7.2 Hz, 3H); 13C NMR (CD3OD): d=
145.1, 140.4, 123.9, 122.5, 120.8„ 49.9, 47.0, 42.7, 34.2, 31.8, 19.2, 12.3, 8.5;
19F NMR (CD3OD): d=À80.6; IR (KBr, cmÀ1): n˜ = 3150 (s), 2966 (s),
2879 (s), 2391 (w), 1592 (m), 1539 (m), 1456 (s), 1352 (vs), 1191 (vs),
1139 (vs), 1038 (vs), 946 (w), 835 (w), 789 (s), 763 (s), 741 (s), 655 (m),
616 (vs), 571 (s), 514 (s); elemental analysis (%) calcd for
C14H20F6N6O4S2 (514.4): C 32.68, H 3.92, N 16.34; found C 32.62, H 3.90,
N 16.37.
1-[(1-Benzyl-1H-1,2,3-triazol-4-yl)methyl]-3-methylimidazol-3-ium bro-
mide (3d): Yellow solid, yield: 87%. 1H NMR ([D6]DMSO): d=9.22 (s,
1H), 8.34 (s, 1H), 7.76 (s, 1H), 7.70 (s, 1H), 7.38–7.33 (m, 5H), 5.63 (s,
2H), 5.54 (s, 2H), 3.86 (s, 3H). 13C NMR ([D6]DMSO): d=141.2, 137.1,
136.1, 129.3, 128.8, 128.6, 125.1, 124.3, 122.8, 53.5, 44.0, 36.3.
1-Butyl-2-methyl-3-[(1-butyl-1H-1,2,3-triazol-4-yl)methyl]-1H-imidazol-3-
ium bromide (3e): Brown oil, yield: 60%. 1H NMR (CD3OD): d=8.28
(s, 1H), 7.62 (s, 2H), 5.57 (s, 2H), 4.45 (t, J=8 Hz, 2H), 4.22 (t, J=8 Hz,
2H), 2.82 (s, 3H), 1.96–1.80 (m, 4H), 1.45–1.30 (m, 4H), 1.05–0.95 (m,
6H); 13C NMR (CD3OD): d=144.5, 140.4, 124.2, 121.4, 121.3, 49.9, 47.2,
42.8, 31.9, 31.3, 19.3, 19.2, 12.5, 12.4, 8.95.
1-Butyl-3-[(1-butyl-1H-1,2,3-triazol-4-yl)methyl]-1H-imidazol-3-ium bro-
mide (3 f): Brown oil, yield: 65%. 1H NMR (CD3OD): d=9.20 (s, 1H),
8.27 (s, 1H), 7.71 (s, 2H), 5.61 (s, 2H), 4.46 (t, J=8 Hz, 2H), 4.28 (t, J=
8 Hz, 2H), 1.96–1.85 (m, 4H), 1.45–1.30 (m, 4H), 1.05–0.95 (m, 6H);
13C NMR (CD3OD): d=140.2, 136.1, 124.5, 122.6, 122.4, 49.9, 49.4, 43.8,
31.8, 31.7, 19.2, 19.1, 12.4, 12.3.
1-Methyl-3-[(1-butyl-1H-1,2,3-triazol-4-yl)methyl]-1H-imidazol-3-ium
bis(trifluoromethylsulfonyl)amide (4d): Brown oil, yield: 90%. 1H NMR
(CD3OD): d=8.96 (s, 1H), 8.15 (s, 1H), 7.64 (s, 1H), 7.58 (s, 1H), 5.55
(s, 2H), 4.44 (t, J=7.2 Hz, 2H), 3.95 (s, 3H), 1.93–1.85 (m, 2H), 1.40–
1.30 (m, 2H), 0.97 (t, J=7.6 Hz, 3H); 13C NMR (CD3OD): d=140.2,
124.3, 123.8, 122.3, 121.4, 118.2, 50.0, 43.8, 35.2, 31.8, 19.2, 12.3; 19F NMR
(CD3OD): d=À80.6; IR (KBr, cmÀ1): n˜ = 3156 (m), 2966 (m), 2879 (w),
2111 (w), 1575 (w), 1455 (w), 1353 (vs), 1595 (vs), 1138 (s), 1058 (vs), 842
(w), 788 (m), 741 (w), 617 (s), 571 (m), 514 (m); elemental analysis (%)
calcd for C13H18F6N6O4S2 (500.4): C 31.20, H 3.63, N 16.79; found C
31.16, H 3.73, N 17.65.
1-Butyl-3-[(1-phenyl-1H-1,2,3-triazol-4-yl)methyl]imidazol-3-ium
bro-
mide (3g): Brown solid, yield: 50%. 1H NMR ([D6]DMSO): d=9.44 (s,
1H), 9.03 (s, 1H), 7.92–7.87 (m, 4H), 7.63 (t, J=8.2 Hz, 2H), 7.53 (t, J=
7.2 Hz, 1H), 5.68 (s, 2H), 4.22 (t, J=7.24 Hz, 2H), 1.82–1.74 (m, 2H),
1.30–1.22 (m, 2H), 0.90 (t, J=7.2 Hz, 3H); 13C NMR([D6]DMSO): d=
142.0, 136.9, 136.8, 130.5, 129.5, 123.7, 123.2, 120.7, 49.2, 44.2, 31.78, 19.3,
13.7.
1,2-Dimethyl-3-[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]-1H-imidazol-3-
ium hexafluorophosphate (4e): Colorless solid, yield: 80%. 1H NMR
(CD3OD): d=8.10 (s, 1H), 7.47 (s, 1H), 7.43 (s, 1H), 7.40–7.30 (m, 5H),
5.60 (s, 2H), 5.46 (s, 2H), 3.81 (s, 3H), 2.70 (s, 3H); 13C NMR (CD3OD):
d=145.1, 140.9, 135.1, 128.7, 128.3, 127.9, 124.0, 122.5, 120.8, 53.7, 42.6,
34.1, 8.4; 31P NMR: d=À144.6; 19F NMR (CD3OD): d=À74.3 (d, J=
706 Hz, 6F); IR (KBr, cmÀ1): n˜ = 3158 (s), 3090 (w), 3035 (w), 2964 (w),
1590 (m), 1537 (m), 1455 (m), 1371 (w), 1329 (w), 1125 (m), 1054 (m),
840 (vs), 748 (s), 722 (m), 559 (s); elemental analysis (%) calcd for
C15H18F6N5P (413.3): C 43.59, H 4.39, N 16.94, Found C 43.42, H 4.62, N
15.96.
1-[(1-Benzyl-1H-1,2,3-triazol-4-yl)methyl]-3-butyl-1H-imidazol-3-ium
bromide (3h):[34] Brown solid, yield: 91%. 1H NMR ([D6]DMSO): d=
9.31 (s, 1H), 8.34 (s, 1H), 7.78 (d, J=7.6 Hz, 2H,), 7.40–7.32 (m, 5H),
5.64 (s, 2H), 5.54 (s, 2H), 4.18 (t, J=7.2 Hz, 2H), 1.78–1.72 (m, 2H),
1.26–1.21 (m, 2H), 0.88 (t, J=7.2 Hz, 3H). 13C NMR ([D6]DMSO): d=
141.2, 136.6, 136.1, 129.3, 128.8, 128.5, 125.1, 123.1, 123.1, 53.5, 49.2, 44.1,
31.8, 19.2, 13.7.
1-[(1-Benzyl-1H-1,2,3-triazol-4-yl)methyl]-3-mesitylimidazol-3-ium bro-
mide (3i): Brown solid, yield: 84%. 1H NMR ([D6]DMSO): d=9.56 (s,
1H), 8.38 (s, 1H), 8.04 (s, 1H), 7.91 (s, 1H), 7.39–7.32 (m, 5H), 7.14 (s,
2H), 5.66 (d, J=3.6 Hz, 4H), 2.32 (s, 3H), 1.99 (s, 6H,); 13C NMR
([D6]DMSO): d=141.1, 140.8, 138.2, 136.1, 134.7, 131.5, 129.7, 129.3,
128.8, 128.5, 125.1, 124.5, 123.7, 53.5, 44.7, 21.0, 17.3.
1,2-Dimethyl-3-[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]-1H-imidazol-3-
ium bis(trifluoromethylsulfonyl)amide (4 f): Colorless oil, yield: 89%.
1H NMR (CD3OD): d=8.12 (s, 1H), 7.50 (s, 1H), 7.45 (s, 1H), 7.40–7.30
(m, 5H), 5.61 (s, 2H), 5.48 (s, 2H), 3.82 (s, 3H), 2.72 (s, 3H); 13C NMR
(CD3OD): d=145.1, 141.0, 135.0, 128.7, 128.3, 127.8, 123.9, 122.5, 120.8,
53.8, 42.6, 34.1, 8.4; 19F NMR (CD3OD): d=À80.6; IR (KBr, cmÀ1): n˜ =
3150 (s), 3094 (w), 3027 (w), 2964 (w), 2390 (vw), 1592 (m), 1539 (m),
1498 (w), 1456 (m), 1352 (vs), 1195 (vs), 1139 (vs), 1056 (vs), 798 (m),
741 (s), 654 (m), 616 (s), 671 (s), 514 (s), 464 (vw); elemental analysis
General procedure for the preparation of 4a–4n: KPF6 (2.0 mmol) or
LiNACHTUNGTRENNUNG(SO2CF3)2 (2.0 mmol) was added to a solution of 3a–3i (1.0 mmol) in
a mixture of water (5 mL) and acetone (5 mL) at room temperature. The
resulting mixture was stirred at 258C for 12 h. Acetone was removed
under reduced pressure, and the water layer was extracted with ethyl ace-
7848
ꢀ 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2012, 18, 7842 – 7851